Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: A clinicopathologic study of 125 cases

Virchows Archiv

Volumn 452, Issue 1, 2008, Pages 49-55

  Lim, So Dug ^a,b   Young, Andrew N ^c   Paner, Gladell P ^d   Amin, Mahul B ^e  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

CD44; Immunohistochemistry; Metastasis; Prognosis; Renal cell carcinoma

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; LYMPHOCYTE ANTIBODY;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANTIGENS, CD44; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 37549036317     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0530-4     Document Type: Article

References (23)

1. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281-291
2. Daniel L, Lechevallier E, Giorgi R, Lindner V, De Fromont M, Vieillefond A, Coulange C, Figarella-Branger D (2001) CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas. J Pathol 193:345-349
3. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25:275-284
4. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ (2004) CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 64:5702-5711
5. Fischer C, Georg C, Kraus S, Terpe HJ, Luedecke G, Weidner W (1999) CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma. Anticancer Res 19:1513-1517
6. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663
7. Gilcrease MZ, Guzman-Paz M, Niehans G, Cherwitz D, McCarthy JB, Albores-Saavedra J (1999) Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Cancer 86:2320-2326
8. Gilcrease MZ, Truong L, Brown RW (1996) Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas. Hum Pathol 27:1355-1360
9. Greene FL, Compton CC, Fritz AG et al (eds) (2006) American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edn. Springer, New York, NY, pp 315-322
10. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
11. Harik LR, Pashaei S, Humphrey PA, Tamboli P, Amin MB (2005) Needle core biopsy of the kidney for mass lesions: A clinicopathologic perspective based on 196 cases. Mod Pathol 18:144A (Abstract)
12. Hill A, McFarlane S, Johnston PG, Waugh DJ (2006) The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Lett 237:1-9
13. Li N, Tsuji M, Kanda K, Murakami Y, Kanayama H, Kagawa S (2000) Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma. Br J Urol Int 85:514-518
14. Liao HX, Lee DM, Levesque MC, Haynes BF (1995) N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J Immunol 155:3938-3945
15. Moch H, Sauter G, Buchholz N, Gasser TC, Bubendorf L, Waldman FM, Mihatsch MJ (1997) Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma. Hum Pathol 28:1255-1259
16. Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwége P, Jardin A, Benoît G, Bedossa P (1999) CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol 161:1984-1987
17. Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, Chan T, Ramee MP, Lobel B, Moulinoux JP (2001) Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 32:1209-1215
18. Ross JS, Sheehan CE, Williams SS, Malfetano JH, Szyfelbein WM, Kallakury BV (2001) Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol 116:122-128
19. Ross JS, del Rosario AD, Bui HX, Kallakury BV, Okby NT, Figge J (1996) Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod Pathol 9:854-860
20. Russo P (2004) Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy. Nat Clin Pract Urol 1:26-30
21. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kuhn R, Wittekind CW (1997) Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas. Anticancer Res 17:1155-1162
22. Tawfik OW, Kramer B, Shideler B, Danley M, Kimler BF, Holzbeierlein J (2007) Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. Arch Pathol Lab Med 131(2):261-267
23. Terpe HJ, Störkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Günthert U (1996) Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 148:453-463